Trial · NCT02915302
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 54 | 949 | |
| other | Diarrhoea | Gastrointestinal disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 58 | 992 | |
| other | Vomiting | Gastrointestinal disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 115 | 949 | |
| other | Vomiting | Gastrointestinal disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 109 | 992 | |
| other | Crying | General disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 302 | 949 | |
| other | Crying | General disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 321 | 992 | |
| other | Injection site erythema | General disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 210 | 949 | |
| other | Injection site erythema | General disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 228 | 992 | |
| other | Injection site pain | General disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 430 | 949 | |
| other | Injection site pain | General disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 473 | 992 | |
| other | Injection site swelling | General disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 117 | 949 | |
| other | Injection site swelling | General disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 138 | 992 | |
| other | Pyrexia | General disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 151 | 949 | |
| other | Pyrexia | General disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 164 | 992 | |
| other | Upper respiratory tract infection | Infections and infestations | Fluzone Quadrivalent Vaccine, 0.25-mL | 69 | 949 | |
| other | Upper respiratory tract infection | Infections and infestations | Fluzone Quadrivalent Vaccine, 0.5-mL | 70 | 992 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 249 | 949 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 267 | 992 | |
| other | Somnolence | Nervous system disorders | Fluzone Quadrivalent Vaccine, 0.25-mL | 292 | 949 | |
| other | Somnolence | Nervous system disorders | Fluzone Quadrivalent Vaccine, 0.5-mL | 294 | 992 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02915302/events